IM Cannabis Corp.
CAD2.2
-0.26 (-10.57%)
IMCC.CN Price Chart
| Basic | |
|---|---|
| Market Cap | CAD9.41M |
| Price | CAD2.2 |
| 52 Week Range | 2.16-10.68 |
| Beta | 2.10 |
| Margins | |
| Gross Profit Margin | 15.64% |
| Operating Profit Margin | -50.44% |
| Net Profit Margin | -19.59% |
| Valuation (TTM) | |
| P/E Ratio | -0.40 |
| Price to Sales Ratio | 0.11 |
| Price to Book Ratio | 0.80 |
| PEG Ratio | 0.05 |
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
Full-Time Employees
95
Website
IPO Date
1996-08-08T00:00:00.000Z
Description
IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. It offers cannabis flowers and strain specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, and pressed hash offerings under the WAGNERS and Highland Grow brands. The company serves medical patients and adult-use recreational consumers. IM Cannabis Corp. is headquartered in Tel Aviv-Yafo, Israel.
Phone
972 5 44331111
Address
Kibbutz Glil Yam, Tel Aviv, 4690500, IL